49282 Federal Register / Vol. 72, No.

166 / Tuesday, August 28, 2007 / Notices

DEPARTMENT OF HEALTH AND with § 514.115 Withdrawal of approval Communications Messages. Type of
HUMAN SERVICES of applications (21 CFR 514.115), notice Information Collection Request: NEW.
is given that approval of NADA 128– Need and Use of Information Collection:
Food and Drug Administration 550, and all supplements and This is a request for clearance to pretest
[Docket No. 2007N–0324] amendments thereto, are hereby messages, materials and program
withdrawn, effective August 28, 2007. activities produced for the NIAID HIV
Withdrawal of Approval of a New In a final rule published elsewhere in Vaccine Research Education Initiative
Animal Drug Application; Bacitracin this issue of the Federal Register, FDA (NHVREI). The primary objectives of the
Zinc is amending the animal drug regulations pretests are to (1) Assess audience
to reflect the withdrawal of approval of knowledge, attitudes, behaviors and
AGENCY: Food and Drug Administration, this NADA.
HHS. other characteristics for the planning/
Dated: August 20, 2007. development of health messages,
ACTION: Notice.
Stephen F. Sundlof, education products, communication
SUMMARY: The Food and Drug Director, Center for Veterinary Medicine. strategies, and public information
Administration (FDA) is withdrawing [FR Doc. E7–16985 Filed 8–27–07; 8:45 am] programs; and (2) pretest these health
approval of a new animal drug BILLING CODE 4160–01–S
messages, products, strategies, and
application (NADA) for a bacitracin zinc program components while they are in
Type A medicated article. In a final rule developmental form to assess audience
published elsewhere in this issue of the DEPARTMENT OF HEALTH AND comprehension, reactions, and
Federal Register, FDA is amending the HUMAN SERVICES perceptions. The information obtained
animal drug regulations to remove from audience research and pretesting
portions reflecting approval of this National Institutes of Health results in more effective messages,
NADA. materials, and programmatic strategies.
FOR FURTHER INFORMATION CONTACT:
Proposed Collection; Comment By maximizing the effectiveness of these
Pamela K. Esposito, Center for Request; Pretesting of NIAID’s HIV messages and strategies for reaching
Veterinary Medicine (HFV–212), Food Vaccine Research Communications targeted audiences, the frequency with
and Drug Administration, 7519 Standish Messages which publications, products, and
Pl., Rockville, MD 20855, 301–827– SUMMARY: In compliance with the programs need to be modified is
7818; e-mail: requirement of section 3506(c)(2)(A) of reduced. Frequency of Response: On
pamela.esposito@fda.hhs.gov. the Paperwork Reduction Act of 1995, occasion. Affected Public: Individuals.
SUPPLEMENTARY INFORMATION: Pennfield for opportunity for public comment on Type of Respondents: Adults at risk for
Oil Co., 14040 Industrial Rd., Omaha, proposed data collection projects, the HIV/AIDS, particularly those who are
NE 68144, has requested that FDA National Institute of Allergy and Black/African-American, Hispanic/
withdraw approval of NADA 128–550 Infectious Diseases (NIAID), the Latino, or men who have sex with men;
for ANCHOR Zinc Bacitracin Type A National Institutes of Health (NIH) will healthcare providers; representatives of
medicated article because the product is publish periodic summaries of proposed organizations disseminating HIV-related
not manufactured or marketed. projects to be submitted to the Office of messages or materials. The annual
Therefore, under authority delegated Management and Budget (OMB) for reporting burden is shown in the table
to the Commissioner of Food and Drugs review and approval. below. There are no Capital Costs to
and redelegated to the Center for Proposed Collection: Title: Pretesting report. There are no Operating or
Veterinary Medicine, and in accordance of NIAID’s HIV Vaccine Research Maintenance Costs to report.

Estimated
Estimated Average Estimated total
number of
Type of respondents number of burden hours annual burden
responses per
respondents per response hours requested
respondent

At-risk Adults ................................................................................................ 3,374 1 .3422 1155

Healthcare providers .................................................................................... 50 1 .75 37.5
Organization Gatekeepers ........................................................................... 75 1 .50 37.5

Total ...................................................................................................... 3,499 ........................ .......................... 1230

Request for Comments: Written the quality, utility, and clarity of the Director, Vaccine Research Program,
comments and/or suggestions from the information to be collected; and (4) Division of AIDS, NIAID, NIH, 6700B
public and affected agencies are invited Ways to minimize the burden of the Rockledge Dr., Bethesda, MD 20892–
on one or more of the following points: collection of information on those who 7628, or call non-toll-free number 301–
(1) Whether the proposed collection of are to respond, including the use of 402–0846, or e-mail your request,
information is necessary for the proper appropriate automated, electronic, including your address to
performance of the function of the mechanical, or other technological kripkek@niaid.nih.gov.
agency, including whether the collection techniques or other forms of
Comments Due Date: Comments
information will have practical utility; information technology.
regarding this information collection are
pwalker on PROD1PC71 with NOTICES

(2) The accuracy of the agency’s FOR FURTHER INFORMATION: To request best assured of having their full effect if
estimate of the burden of the proposed more information on the proposed received within 60 days of the date of
collection of information, including the project or to obtain a copy of the data this publication.
validity of the methodology and collection plans and instruments,
assumptions used; (3) Ways to enhance contact Katharine Kripke, Assistant

VerDate Aug<31>2005 19:52 Aug 27, 2007 Jkt 211001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\28AUN1.SGM 28AUN1